Research output per year
Research output per year
Fingerprint
Dive into the research topics where Sarah Hochmann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
BEATS - MIGRANE: Biomarker Etablishment of Activated Targets in Skin for Migrane
Zwicklhuber, J., Hochmann, S. (Co-author), Stefani, A. (Co-author), Wolf, M. (Co-author), Poupardin, R. (Co-author), Maeding, N. (Co-author), Leis, S. (Co-author), Weber, D. (Co-author), Tevini, J. (Co-author), Kofler, B. (Co-author), Russe, E. (Co-author) & Strunk, D. (Co-author), 28 Jun 2024, (Submitted).Research output: Contribution to conference › Poster › peer-review
-
Lack of Effect of Platelet- and Stromal Cell-derived EVs on Inflammation-induced 3D Chondrogenesis
Morávek, M., Wolf, M. (Co-author), Hochmann, S. (Co-author), Maeding, N. (Co-author), Lopes Pedroso, L. (Co-author), Stefani, A. (Co-author), Zwicklhuber, J. (Co-author), Raninger, A. (Co-author), Schallmoser, K. (Co-author) & Strunk, D. (Co-author), 16 Sept 2024.Research output: Contribution to conference › Poster › peer-review
-
A protein corona around human platelet-derived EVs promotes regenerative functions
Schallmoser, K., Gueths Gomes, F., Cronemberger Andrade, A., Wolf, M., Hochmann, S., Krisch, L., Maeding, N., Regl, C., Poupardin, R., Ebner-Peking, P., Huber, C., Meissner-Kober, N. & Strunk, D., 2023.Research output: Contribution to conference › Abstract
-
A protein corona around human platelet-derived EVs promotes regenerative functions
Schallmoser, K., Gueths Gomes, F., Cronemberger Andrade, A., Wolf, M., Hochmann, S., Krisch, L., Maeding, N., Regl, C., Poupardin, R., Ebner-Peking, P., Huber, C., Meissner-Kober, N. & Strunk, D., 2023.Research output: Contribution to conference › Abstract
-
A Protein Corona around Human Platelet-derived EVs Promotes Regenerative Functions
Gueths Gomes, F., Schallmoser, K., Cronemberger Andrade, A., Wolf, M., Hochmann, S., Krisch, L., Maeding, N., Regl, C., Poupardin, R., Ebner-Peking, P., Huber, C., Meissner-Kober, N. & Strunk, D., 2023.Research output: Contribution to conference › Abstract
-
Establishment of biomarkers for migraine in the skin: A special focus on thermoreceptors
Russe, E. (PI), Leis, S. (CoPI), Hochmann, S. (CoPI), Weber, D. (CoPI) & Rinnerthaler , M. (CoPI)
1/04/24 → 31/03/27
Project: Research
-
scarRNA: mRNA-based therapeutics for the Treatment of atrophic scars
Strunk, D. (PI), Mittermeir, M. (Further contributor) & Hochmann, S. (Further contributor)
1/08/17 → 1/09/18
Project: Research
-
3D-chondrogenesis in vitro
Hochmann, S. (Invited speaker)
2017Activity: Talk or presentation › Oral presentation
-
Endogenous mRNA is used to translate genetic information into functional proteins. Together with our collaboration partner ACCANIS we use in vitro transcribed (IVT), exogenously administered RNA that mimics natural mRNA, with modifications that improve its stability and translatability. Towards developing new RNA-based Therapies we are currently validating various therapeutic targets in skin explant cultures and different stem cell models
Hochmann, S. (Cooperation)
2016Activity: Other scientific activities › Cooperation
-
Regeneration of injured tissues requires effective therapeutic strategies supporting vasculogenesis. The lack of instantly available autologous cell sources and immunogenicity of allogeneic endothelial (progenitor) cells limits clinical progress. Based on the immunosuppressive potency of mesenchymal stem/progenitor cells (MSCs), we investigated whether crosstalk between endothelial colony-forming progenitor cells (ECFCs) and MSCs during vasculogenesis could lower allogeneic T cell responses against ECFCs allowing long-term engraftment in vivo. Crosstalk between UC-derived ECFCs and MSCs after combined transplantation can lower the risk of ECFC rejection, thus enabling their coapplication for therapeutic vasculogenesis. Stem Cells 2017;35:1233-1245.
Hochmann, S. (Cooperation)
2010Activity: Other scientific activities › Cooperation